Abstract:In this Q&A, Cell Metabolism’s Scientific Editor Rosalind Mott talks to Prof. Zhijian Cai about his paper “UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders” and his experience with publishing through Cell Press Community Review. In this Q&A, Cell Metabolism’s Scientific Editor Rosalind Mott talks to Prof. Zhijian Cai about his paper “UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders” and his experience with publishing through Cell Press Community Review. Cell Press Community Review is a new mechanism that allows for simultaneous submission of a manuscript to multiple Cell Press journals. A central aim of this approach is to provide authors with more choice when publishing their cross-disciplinary research when it fits the scope of more than one journal. This multi-submission approach can also save authors time without the need for sequential, often time-consuming, submissions to different journals. Here, we present a new paper, which was submitted to Cell Press Community Review and ultimately published in Cell Metabolism, that reports on how ubiquitin-conjugating enzyme E2M (UBE2M) plays a role in obesity-related inflammation and how E3 ubiquitin ligase TRIM21 may be targeted to treat metabolic disorder. The author, Prof. Zhijian Cai, also discusses his experience of publishing through the Cell Press Community Review process. Our story is about how inflammation originates during obesity. Obesity initiates IL-1β-mediated inflammation by upregulating HIF-1α in macrophages. UBE2M incites this process through neddylating TRIM21, stabilizing HIF-1α by recruiting and degrading the Von Hippel-Lindau (VHL) tumor suppressor, thereby aggravating obesity and related metabolic disorders. Obesity also upregulates UBE2M, forming a positive feedback loop. Therefore, we elucidate why inflammation persists and worsens in obese individuals. After being loaded with Trim21 antisense oligonucleotides, extracellular vesicles (EVs) can effectively target macrophages and downregulate their TRIM21, thus alleviating inflammation, which benefits the treatment of obesity and related metabolic disorders. These results provide a proof of concept that macrophage TRIM21 may be an effective target for obesity intervention. My lab mainly focuses on the study of extracellular vesicles and immune regulation, including the utilization of extracellular vesicles as carriers to treat immune-related diseases. When studying macrophage UBE2M’s role in antiviral immunity—a study which has been published in Cell Reports—we accidentally found that older mice with macrophage UBE2M deficiency were significantly thinner than wild-type mice. After detecting some indicators, we found that the fat deposition in the livers of these mice was significantly reduced; this was accompanied by reduced macrophage inflammatory responses. Therefore, we speculated that there must be some fascinating phenomena and resolved to carry out this study. Community Review is an efficient submission system allowing authors to submit to many journals under Cell Press simultaneously, greatly saving their time. Furthermore, the author can roughly understand their article level per the editor’s decision, benefiting more targeted submissions in the future. I was familiar with Community Review before submitting this article. It had no formatting requirements, which was very convenient. At the same time, the editor’s decision and reply were very timely. The peer review time was a little long. The first peer review took nearly three months, which was somewhat overwhelming. However, the reviewers’ comments were very professional. They pointed out many flaws in our study very accurately. By addressing these flaws, I feel that our article’s quality was greatly improved. Sure. Because it is an efficient submission system, and the editors, such as Dr. Sejal Vyas and Bruce Koppelman, are also very nice. Previously, one of our submissions was sent out for peer review by Immunity and Developmental Cell. Although the reviewers’ opinions made the editor reject our article, the editor still kindly gave us a chance to resubmit after properly replying to the reviewers’ questions. As I mentioned above, I hope that the peer review time can be shorter in the future. No, I do not have experience with non-traditional systems. However, I think the double-blind review system will be more scientific and fair. Science is science and should not be colored by personal emotions. Many excellent scientists in the world have done very outstanding work in their own fields. If reviewers see a submission from such authors, they are likely to have preconceived positive emotions, which is likely not to happen for some unknown contributors. I suggest that, when submitting a manuscript, the choice of double-blind review be considered mandatory. The authors declare no competing interests. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disordersLu et al.Cell MetabolismJune 20, 2023In BriefLu et al. show that obesity initiates IL-1β-mediated inflammation by upregulating HIF-1α. UBE2M incites this process by neddylating TRIM21, which stabilizes HIF-1α by recruiting and degrading VHL, thereby aggravating obesity and related metabolic disorders. Obesity also upregulates UBE2M, forming a positive feedback loop, which is effectively prevented by RBC-EVs/Trim21 ASOs. Full-Text PDF

The Hydrophilic Metabolite UMP Alleviates Obesity Traits through a HIF2α‐ACER2‐Ceramide Signaling Axis

The Metabolic Footprint During Adipocyte Commitment Highlights Ceramide Modulation As an Adequate Approach for Obesity Treatment

The Effects of New Selective PPARα Agonist CP775146 on Systematic Lipid Metabolism in Obese Mice and Its Potential Mechanism.

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Meet the Author: Professor Zhijian Cai

The Hexane Extract of Citrus sphaerocarpa Ameliorates Visceral Adiposity by Regulating the PI3K/AKT/FoxO1 and AMPK/ACC Signaling Pathways in High-Fat-Diet-Induced Obese Mice

Adipose Tissue‐Resident Sphingomonas Paucimobilis Suppresses Adaptive Thermogenesis by Reducing 15‐HETE Production and Inhibiting AMPK Pathway

Systemic inhibition of de novo purine biosynthesis prevents weight gain and improves metabolic health by increasing thermogenesis and decreasing food intake

Multiomics reveals the ameliorating effect and underlying mechanism of aqueous extracts of polygonatum sibiricum rhizome on obesity and liver fat accumulation in high-fat diet-fed mice

High temperature ameliorates high-fat diet-induced obesity by promoting ceramide breakdown in skeletal muscle tissue

Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue

PM2.5, component cause of severe metabolically abnormal obesity: An in silico, observational and analytical study

Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15

The phytochemical hyperforin triggers thermogenesis in adipose tissue via a Dlat-AMPK signaling axis to curb obesity

Low-intensity pulsed ultrasound improves metabolic dysregulation in obese mice by suppressing inflammation and extracellular matrix remodeling

Omega-3 PUFA Ameliorates Hyperhomocysteinemia-Induced Hepatic Steatosis in Mice by Inhibiting Hepatic Ceramide Synthesis.

Amelioration of high-fat diet-induced obesity and its associated complications by a myricetin derivative-rich fraction from Syzygium malaccense in C57BL/6J mice

Dihydromyricetin ameliorates diet-induced obesity and promotes browning of white adipose tissue by upregulating IRF4/PGC-1α

Abstract MP31: Serum Metabolite Signatures for Metabolic Healthy and Unhealthy Obesity: The Bogalusa Heart Study

Polyphenol Compound 18a Modulates UCP1-Dependent Thermogenesis to Counteract Obesity

Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota